In accordance with a recent report that showed no correlation between PD-L1 expression and tumor mutational burden (TMB) in most cancer types [19], the TMB of PD-L1 + BTC was comparable to that of PD-L1-BTC (p = 0.630, Fig. S3). This evidence concerns the gene CD274 and cancer.